CNBC

AbbVie bets $10.9 billion on Apogee in next-generation immunology growth push (opens in new tab)

Covered by Yahoo Finance

AbbVie said on Monday it would buy biotech Apogee ⁠Therapeutics for $10.9 billion, in more than ​five years.

Read the original article
Sign in to keep reading the full article.
Sign UpLog In

Covered in 1 article

Yahoo Finance·

AbbVie acquires Apogee Therapeutics for $10.9 billion

Feeds

Keyboard Shortcuts

Navigation

Next / previous post
j/k
Open post
oorEnter
Preview post
v

Post Actions

Love post
a
Like post
l
Dislike post
d
Undo reaction
u
Save / unsave
s

Recommendations

Add interest / feed
Enter
Not interested
x

Go to

Home
gh
Interests
gi
Feeds
gf
Likes
gl
History
gy
Changelog
gc
Settings
gs
Discover
gb
Search
/

General

Show this help
?
Submit feedback
!
Close modal / unfocus
Esc

Press ? anytime to show this help